ABI Shares Up 13 Percent as Fiscal Q1 Revenue Surges | GenomeWeb
NEW YORK (GenomeWeb News) — Shares in Applied Biosystems were up 13.04 percent, or $4.40, at $37.91 in mid-afternoon trading today after the company said fiscal first quarter revenues increased 15 percent.
Separately today, investment bank UBS upgraded ABI’s stock to ‘Neutral’ from ‘Reduce.’

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.